HI

Hiron-Trade Investments & Industrial Buildings Ltd.

HRON | TA

Overview

Corporate Details

ISIN(s):
IL0001500110
LEI:
Country:
Israel
Address:
20 Ben Zvi Rd, 6816215 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Hiron develops and manufactures electronic and communication systems for defense and civilian use.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Hiron-Trade Investments & Industrial Buildings Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-06 18:40
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of May 4th 202…
Hebrew (modern) 245.6 KB
2024-10-28 18:31
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of November 10…
Hebrew (modern) 65.0 KB
2023-10-19 20:07
Regulatory News Service
Candidates securities not to be included in the Illiquid list as of November 5t…
Hebrew (modern) 190.9 KB

Automate Your Workflow. Get a real-time feed of all Hiron-Trade Investments & Industrial Buildings Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hiron-Trade Investments & Industrial Buildings Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Oncodesign Precision Medicine S.A Logo
Develops therapies & diagnostics for resistant and metastatic cancers.
France ALOPM
Oncoinvent ASA Logo
Developing alpha-emitting radiopharmaceuticals like Radspherin® for localized cancer treatment.
Norway OCIN
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ
Onxeo Logo
Developing precision therapies for complex diseases using a proprietary single-domain antibody platform.
France ALONX
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
Oramed Pharmaceuticals Inc. Logo
Developing oral drug delivery systems to replace injections, like an oral insulin capsule.
Israel ORMP
Oryzon Genomics S.A. Logo
Advancing epigenetic therapeutics for oncology and central nervous system disorders.
Spain ORY
OSE Immunotherapeutics Logo
Developing first-in-class immunotherapies for immuno-oncology and immuno-inflammation.
France OSE
Ovoca Bio Plc Logo
Clinical-stage biopharma developing novel treatments for female sexual dysfunction.
Ireland OVXA
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD